strike digital currency Top See results about

Xi 'an Aisheng Group: It is planned to conduct a comprehensive benchmarking survey on financial and internal control according to the asset securitization standards, and the Ordnance Industry Group issued the Comprehensive Financial and Audit Services Project of Xi 'an Aisheng Technology Group Co., Ltd. on the procurement e-commerce platform. The announcement shows that the project will conduct a comprehensive benchmarking survey on the purchaser's financial and internal control situation in accordance with the asset securitization standards, put forward rationalization suggestions, and issue a best-effort report. At the same time, review the annual financial statements of the purchaser during the standardized period, and assist the purchaser to complete the annual final accounts and tax returns; Cooperate with other intermediaries in their daily work. According to the requirements, the supplier must have the audit performance of similar asset securitization projects undertaken since January 1, 2021, and the project leader must have the successful project performance signed by two or more audit reports of similar asset securitization projects. According to the data, Xi 'an Aisheng Group is one of the earliest units engaged in the development and production of UAV systems in China. In 2009, 2017 and 2019, the developed products participated in the military parade of the 60th anniversary of the National Day, the 90th anniversary of the founding of the People's Republic of China and the 70th anniversary of the National Day. In addition, Inner Mongolia No.1 Machinery Co., Ltd. (600967), which is also a subsidiary of China Ordnance Industry Group, just announced on December 7 that it plans to increase its capital with related parties. Upon completion, the company will hold 4.27% of its shares, and together with the actual controller China Ordnance Industry Group and concerted parties, it will hold 52.15% of its shares.Chuanrun helps Goldwind Technology roll off the production line of a new generation of deep-sea 22MW offshore wind turbines. According to Sichuan Chuanrun Co., Ltd., recently, Goldwind Technology successfully rolled off the production line of a new generation of deep-sea 22MW offshore wind turbines in Shantou manufacturing base, setting a new record for Guangdong's largest single-unit capacity offshore wind turbines. As a key technical partner, Chuanrun provided a complete set of cooling system and lubrication system for the unit, which demonstrated the company's technical strength and innovation ability in the field of wind power.Laiyifen set up a business development company including integrated circuit business. The enterprise search APP shows that recently, Shanghai Laiyifen Future Domain Business Development Co., Ltd. was established, with the legal representative of Yu Ruifen and the registered capital of 1 million yuan. Its business scope includes: the second type of value-added telecommunications business; Internet information service; Communication equipment sales; Integrated circuit chips and product sales; Integrated circuit sales, etc. Enterprise investigation shows that the company is wholly owned by Laiyi.

Police in Xichang, Sichuan: A man who knocked down a pedestrian after drinking and driving killed three people and was detained.Market News: Brian Quintenz has become the top contender for the chairmanship of the Commodity Futures Trading Commission (CFTC).Baijiayun received $15 million in financing. One-stop AI video technology service provider Baijiayun (NASDAQ：RTC) announced that the company had signed a series of important agreements with YA II PN, Ltd, a fund managed by Yorkville Advisors Global and LP. The company received $15 million in financing, and the down payment of $3 million was received on the signing date of the agreement.

China Petroleum and others set up a joint exploration company in Xinjiang with a registered capital of 1 billion yuan. According to the enterprise search APP, PetroChina Tayou Joint Exploration (Xinjiang) Co., Ltd. was recently established, with the legal representative of Liu Weibo and a registered capital of 1 billion yuan. Its business scope includes: mineral resources exploration. Enterprise survey shows that the company is jointly owned by PetroChina Taihu (Beijing) Investment Co., Ltd., a wholly-owned subsidiary of China Petroleum, and Xinjiang Yaxin CBM Investment and Development (Group) Co., Ltd.Rifa Seiki: Xunmi Technology went to the company to investigate and discuss products such as end-horizontal machining center and thread grinder. On December 11th, Xunmi Technology co-president Lei Ming and his party visited and investigated Seiki Seiki in Japan. Chasing technology has visited the production workshop of Maichuang and bearing equipment in depth, and gained an in-depth understanding of the specific situation of products such as high-end horizontal machining center and thread grinder of Nissan Seiki from research and development to production. Not only that, the two sides also conducted in-depth exchanges and discussions on the intelligent production line structure, core components, product accuracy and related issues in the practical application of a complete set of solutions. According to the data, Chasing Technology began to lay out robots in 2021, and successively launched bionic quadruped robot dogs, universal humanoid robots and other products. In September this year, Xunmi Technology released X50 series sweeping robots, equipped with the world's first "bionic mechanical foot obstacle-crossing technology".Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.